print-logo
Logo
  • Healthcare Consultants
  • Healthcare Managers
  • Who we are Arrow Down
    • About us
    • Our team
    • News & events
  • What we do Arrow Down
    • Overview
    • Market Access
    • Medical Affairs
    • Government Affairs
    • Commercial Excellence
    • Patient Affairs
    • Healthcare Improvement
  • Insights Arrow Down
    • Publications
    • Project cases
    • Early Asset Strategy
    • Value Pull-through
    • Environment Transformation
  • Careers Arrow Down
    • Why join us
    • FAQ
  • Contact
  • Search Icon
  • Healthcare Consultants
  • Healthcare Managers
  • Search Icon
  • Search
Back to Our team

Arman Nilforoushan

Director | Zurich, CH

Bild von Arman Nilforoushan

Contact

  • mail_icon a.nilforoushan@executiveinsight.ch
  • linkedin_icon LinkedIn-Profile

Focus Area

Arman focuses on Health Policy, Market Access and Medical Affairs. His experience includes development of value-based healthcare strategies and external engagement toolkits, creation of value communication tools supporting product launches and conceptualization of approaches to improve the patient journey across various therapeutic areas.

Education

PhD in Toxicology from ETH Zurich, MSc in Chemistry from ETH Zurich

Languages

Italian, English, French, German, Persian

I am a huge football fan, a passion that makes me travel hours to see an Italian “Old Lady” dressed in black & white.

How the ‘five Ps’ can close health equity gaps
Publication

How the ‘five Ps’ can close health equity gaps

Understanding and addressing healthcare inequity in the United States
Publication

Understanding and addressing healthcare inequity in the United States

Collaborative, evidence-based decisions the key for successful healthcare policy-making
Publication

Collaborative, evidence-based decisions the key for successful healthcare policy-making

Excellence in Trade Association engagement
Project Case

Excellence in Trade Association engagement

Complete literature list

 

October 26, 2023
Collaborative, evidence-based decisions the key for successful healthcare policy-making

Kellum, A.H; Pallan, P.S.; Nilforoushan, A.; Sturla, S.J.; Stone, M.P.; Egli, M. 
Conformation and Pairing Properties of an O6-Methyl-2′-deoxyguanosine-Directed Benzimidazole Nucleoside Analog in Duplex DNA
Chemical Research in Toxicology, 2022, 35, 10, 1903–1913

Aloisi, C.M.N; Nilforoushan, A.; Ziegler, N.; Sturla S.J.
Sequence-Specific Quantitation of Mutagenic DNA Damage via Polymerase Amplification with an Artificial Nucleotide,
Journal of the American Chemical Society, 2020, 142, 6962-6969

Betz, K.; Nilforoushan, A.; Wyss, L.A.; Diederichs, K.; Sturla, S.J.; Marx A.
Structural basis for the selective incorporation of an artificial nucleotide opposite a DNA adduct by a DNA polymerase,
Chemical Communications, 2017, 53, 12704-12707

Mentegari, E.; Crespan, E.; Bavagnoli, L.; Kissova, M.; Bertoletti, F.; Sabbioneda, S.; Imhof, R.; Sturla, S.J.; Nilforoushan, A.; Hubscher, U.; Van Loon, B.; Maga, G.
Ribonucleotide incorporation by human DNA polymerase η impacts translesion synthesis and RNaseH2 activity,
Nucleic Acids Research, 2017, 45, 2600-2614

Trantakis, I.A.; Nilforoushan A.; Dahlmann H.A.; Stäuble, C.K.; Sturla, S.J.
In-gene Quantification of O6-Methylguanine with Elongated Nucleoside Analogues on Gold Nanoprobes,
Journal of the American Chemical Society, 2016, 138, 8497-8504

Wyss, L.A.*; Nilforoushan, A.*; Williams, D.M.; Marx, A.; Sturla, S.J.
The Use of an Artificial Nucleotide for Polymerase-based Recognition of Carcinogenic O6-alkylguanine DNA Adducts,
Nucleic Acids Research, 2016, 44, 6564-6573. *joint first authors

Nilforoushan, A.; Furrer, A.; Wyss, L.A.; Van Loon, B.; Sturla, S.J.
Nucleotides with Altered Hydrogen Bonding Capacities Impede Human DNA Polymerase η by Reducing Synthesis in the Presence of the Major Cisplatin DNA Adduct,
Journal of the American Chemical Society, 2015, 137, 4728-4734 

Wyss, L.A.; Nilforoushan, A.; Eichenseher F.; Suter, U.; Blatter, N.; Marx, A.; Sturla, S.J.
Specific Incorporation of an Artificial Nucleotide Opposite a Mutagenic DNA Adduct by a DNA Polymerase,
Journal of the American Chemical Society, 2015, 137, 30-33 

Share this page
  • linkedin_icon
  • mail_icon
  • print_icon

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.

OK
arrow_up

How can we help?

Contact us

Our offices

Careers

Footer Logo
  • Who we are
  • What we do
  • Insights
  • Careers
  • Contact
  • Terms of use
  • Privacy policy
  • Imprint

2025 Executive Insight. All rights reserved.